ElizabethSquiersMD

General Surgery • Half Moon Bay, CA

Hepatobiliary Surgery, Pancreas, Transplantation

Physician

Join to view full profile

Dr. Squiers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Squiers' full profile

Already have an account?

Office
229 Myrtle St
Half Moon Bay, CA 94019
Phone+1 650-726-6618

Fax+1 650-726-6602

Summary

Elizabeth Squiers, MD, based in Half Moon Bay, CA, specializes in General Surgery with subspecialties in Hepatobiliary Surgery, Pancreas, and Transplantation. She completed her medical education at Sidney Kimmel Medical College and held fellowships in Abdominal Transplant Surgery at multiple prestigious institutions. With extensive experience in transplant surgery, she transitioned to biotech, where her career includes roles such as Managing Member of Coastal Vista Consulting, and past positions as Chief Medical Officer at Quark Pharmaceuticals and other organizations. She has contributed significantly to research, with several publications focusing on transplant surgery and kidney injury, which have been widely cited. Her work also includes leading numerous clinical trials. Dr. Squiers is recognized as a Fellow of the American College of Surgeons.

Education & Training

Ohio State University HospitalFellowship, Abdominal Transplant Surgery, 1994 - 1994
University of Nebraska Medical Center College of MedicineFellowship, Abdominal Transplant Surgery, 1990 - 1990
University of FloridaFellowship, Abdominal Transplant Surgery, 1988 - 1990
Corewell Health East Beaumont (Royal Oak)Residency, Surgery, 1983 - 1988
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983

Certifications & Licensure

CA State Medical License 2001 - 2027
MI State Medical License 1990 - 2018
PA State Medical License 1990 - 2004
FL State Medical License 1988 - 1991
European Medical AgencyEudravigilance

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome Start of enrollment: 2000 Sep 01
Completed
Phase 2
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. Start of enrollment: 2000 May 01
Completed
Phase 2
YSPSL for Prevention of Delayed Graft Function Part B Start of enrollment: 2006 May 01
Completed
Phase 1, Phase 2
YSPSL for Prevention of Delayed Graft Function Part A Start of enrollment: 2005 Oct 01
Completed
YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation Start of enrollment: 2007 Mar 01
Unknown status
Phase 2
Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome Start of enrollment: 2007 Oct 01
Terminated
Phase 2
A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery Start of enrollment: 2007 Aug 01
Completed
Phase 1
A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004) Start of enrollment: 2008 May 01
Terminated
Phase 1
Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema Start of enrollment: 2008 Jun 01
Terminated
Phase 2
Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). Start of enrollment: 2009 Nov 01
Completed
Phase 2
Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) Start of enrollment: 2007 Feb 01
Completed
Phase 1
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation Start of enrollment: 2008 Dec 01
Completed
Phase 1, Phase 2
YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation Start of enrollment: 2008 May 01
Unknown status
Phase 2
Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients Start of enrollment: 2010 Feb 01
Completed
Phase 1
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) Start of enrollment: 2012 Feb 01
Completed
Phase 2
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG) Start of enrollment: 2013 Dec 01
Completed
Phase 2
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Start of enrollment: 2016 Feb 24
Terminated
Phase 2, Phase 3
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery Start of enrollment: 2015 Dec 01
Completed
Phase 2
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant Start of enrollment: 2016 Mar 01
Completed
Phase 3
QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery Start of enrollment: 2018 Jun 29
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

38 citations
Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study.
Matthias Thielmann, David Corteville, Gábor Szabó, Madhav Swaminathan, Andre Lamy
Circulation. 2021-10-05
29 citations
Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Ac...
Segav Demirjian, Gorav Ailawadi, Martin Polinsky, Dani Bitran, Shuli Silberman
Kidney International Reports. 2017-09-01
51 citations
rPSGL‐Ig for Improvement of Early Liver Allograft Function: A Double‐Blind, Placebo‐Controlled, Single‐Center Phase II Study†
Ronald W. Busuttil, Gerald S. Lipshutz, Jerzy W. Kupiec-Weglinski, S. Ponthieux, David W. Gjertson
American Journal of Transplantation. 2011-04-01

Professional Memberships

American College of Surgeons - ACS
Member

External Links

Coastal Vista Consulting LLChttps://coastalvistaconsulting.com